In defense of data sharing, but done in the right way

(By Jeffrey M. Drazen and Isaac S. Kohane for STAT)

In the mid-1990s, a practice-changing clinical trial1 refined how people with mild asthma use inhaled albuterol. Instead of taking it on a regular schedule, the trial suggested it was better to use albuterol only when asthma symptoms appeared. That trial also had a hidden bonus: It yielded detailed data on inhaler use and asthma symptoms for hundreds of patients with asthma. Those data were used to help design additional trials in similar patients, studies done more quickly and at lower cost. Continue reading article…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.